mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |